Lintong Yao

447 total citations
21 papers, 259 citations indexed

About

Lintong Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lintong Yao has authored 21 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lintong Yao's work include Radiomics and Machine Learning in Medical Imaging (6 papers), RNA modifications and cancer (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lintong Yao is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (6 papers), RNA modifications and cancer (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lintong Yao collaborates with scholars based in China, United States and Germany. Lintong Yao's co-authors include Zhenzhen Chen, Pingping Zhu, Yating Liu, Yanfeng Gao, Haiyu Zhou, Shaowei Wu, Lan Huang, Wenshan Zhao, Haibo Weng and Zhongyi Yan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Lintong Yao

20 papers receiving 258 citations

Peers

Lintong Yao
Ryan Robb United States
Ziqi Jia China
Jiamei Gu China
Karie Runcie United States
Shiqin Liu United States
Lintong Yao
Citations per year, relative to Lintong Yao Lintong Yao (= 1×) peers Yingqiu Song

Countries citing papers authored by Lintong Yao

Since Specialization
Citations

This map shows the geographic impact of Lintong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lintong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lintong Yao more than expected).

Fields of papers citing papers by Lintong Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lintong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lintong Yao. The network helps show where Lintong Yao may publish in the future.

Co-authorship network of co-authors of Lintong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Lintong Yao. A scholar is included among the top collaborators of Lintong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lintong Yao. Lintong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Gang, Ziyi Zhao, Lei Yu, et al.. (2025). A narrative review of the prediction of immunotherapy efficacy for treating NSCLC: An artificial intelligence perspective. 1(3). 193–203. 2 indexed citations
3.
Zeng, Fanjun, et al.. (2024). A Novel Oncolytic Virus Formulation Based on Mesenchymal Stem Cell-Derived Vesicles for Tumor Therapy. Journal of Cancer. 16(3). 700–707. 1 indexed citations
4.
Yao, Lintong, Xiaomei Liu, Ziying Wang, et al.. (2024). Hydrogel-to-Nanoparticle Transition with Immune Cell Activation Controlled by Dual Supramolecular Interactions. ACS Applied Materials & Interfaces. 16(49). 67458–67467. 1 indexed citations
6.
Yao, Lintong, et al.. (2024). Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion. Discover Oncology. 15(1). 149–149. 2 indexed citations
7.
Wu, Shaowei, Lintong Yao, Guoqing Liao, et al.. (2023). Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study. Journal for ImmunoTherapy of Cancer. 11(10). e007369–e007369. 20 indexed citations
8.
Xu, Bin, Fanjun Zeng, Lintong Yao, et al.. (2023). A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy. Bioactive Materials. 27. 337–347. 24 indexed citations
9.
Liu, Shengbo, Lintong Yao, Chenguang Guo, et al.. (2023). Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(17). 15623–15640. 4 indexed citations
11.
Yao, Lintong, Libin Wu, Rujin Wang, et al.. (2022). Liposome-Based Carbohydrate Vaccine for Simultaneously Eliciting Humoral and Cellular Antitumor Immunity. ACS Macro Letters. 11(8). 975–981. 9 indexed citations
12.
Yao, Lintong, Shaowei Wu, Yubo Zhou, et al.. (2022). Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma. Frontiers in Immunology. 13. 944378–944378. 6 indexed citations
13.
Yao, Lintong & Haiyu Zhou. (2022). A potential mechanism of ferroptosis modulation for immunotherapy in LUAD: ceRNAs networks of OTUD6B-AS1 modulate the balance of ubiquitination.. Journal of Clinical Oncology. 40(16_suppl). e15111–e15111. 1 indexed citations
14.
Liu, Rongying, Ran Zhang, Long Li, et al.. (2021). A Comprehensive Landscape for Fibril Association Behaviors Encoded Synergistically by Saccharides and Peptides. Journal of the American Chemical Society. 143(17). 6622–6633. 23 indexed citations
15.
Liao, Guoqing, Shaowei Wu, Peirong Zhang, et al.. (2021). Preoperative CT-based peritumoral and tumoral radiomic features prediction for tumor spread through air spaces in clinical stage I lung adenocarcinoma. Lung Cancer. 163. 87–95. 35 indexed citations
16.
Yu, Yunfang, Lintong Yao, Bin Xu, et al.. (2021). KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials. Frontiers in Oncology. 11. 659200–659200. 17 indexed citations
17.
Yao, Lintong, et al.. (2021). Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 706616–706616. 1 indexed citations
18.
Zheng, Shaopeng, Lintong Yao, Yunfang Yu, et al.. (2021). Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma. PeerJ. 9. e10680–e10680. 4 indexed citations
19.
Chen, Zhenzhen, Yanfeng Gao, Lintong Yao, et al.. (2018). LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. Oncogene. 37(23). 3098–3112. 58 indexed citations
20.
Chen, Zhenzhen, Lintong Yao, Yating Liu, & Pingping Zhu. (2018). LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis. Cancer Letters. 430. 88–96. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026